James Dean, MD
Ophthalmology · Putnam, CTNPI 1083618532
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,086 of the $11,917 with a category attached, or 67.9%. 27 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 27.7% of the total. Reporting peaked in 2022 at $3,257 and has fallen 51.2% since, to $1,588 in 2025. Among ophthalmology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 356 payments — averaging $33.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$3K
- AbbVie$2K
- Rxsight Inc$1K
- Alcon$1K
- Mallinckrodt Hospital Products Inc.$731
- Sun Pharmaceutical Industries Inc.$346
- plus $3K from 21 others
What the payments were for
- Consulting fees$4504%
- Speaking & faculty fees$390%
- Travel & lodging$2,97125%
- Food & beverage$8,08668%
- Education$2983%
- Gifts$731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 9 | $3,303 |
| AbbVie(2 entities) | 113 | $2,336 |
| Rxsight Inc | 36 | $1,359 |
| Alcon | 36 | $1,037 |
| Mallinckrodt Hospital Products Inc. | 26 | $731 |
| Sun Pharmaceutical Industries Inc. | 16 | $346 |
| Harrow Eye, LLC | 4 | $312 |
| Oyster Point Pharma, Inc. | 12 | $301 |
| Kala Pharmaceuticals, Inc. | 15 | $300 |
| Bausch & Lomb Americas Inc. | 14 | $288 |
| Ocular Therapeutix, Inc. | 8 | $222 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 9 | $200 |
| Dompe US, Inc. | 7 | $185 |
| Novartis | 8 | $154 |
| Johnson & Johnson Surgical Vision, Inc. | 10 | $139 |
| Aerie Pharmaceuticals, Inc. | 7 | $121 |
| Tarsus Pharmaceuticals, Inc. | 4 | $106 |
| Glaukos Corporation | 4 | $101 |
| Amgen(2 entities) | 4 | $91 |
| Hoffmann-la Roche Limited | 1 | $69 |
| Biotissue Holdings Inc. | 2 | $46 |
| Sight Sciences, Inc. | 2 | $42 |
| Quidel Corporation | 4 | $41 |
| Merz Pharmaceuticals, LLC | 1 | $29 |
| Eyevance Pharmaceuticals LLC | 2 | $26 |
| Rayner Intraocular Lenses Limited | 1 | $17 |
| Johnson & Johnson Vision Care, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARTEVO 800$1,715
- CIRRUS HD-OCT$1,246
- IOLMaster 700$1,246
- VisuMax$1,246
- QUATERA 700$1,246
- DURYSTA$711
- RXSIGHT CONTACT LENS$445
- RXSIGHT INJECTOR CARTRIDGE$445
- RXSIGHT INJECTOR HANDPIECE$445
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$445
- LIGHT ADJUSTABLE LENS (LAL)$309
- IHEEZO$256
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$136
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$125
- TRYPTYR$120
- PanOptix$118
How this compares
$11,917 in reported general payments places this provider in the 90th percentile of 279 ophthalmology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 176 | $171,489 |
| XiidraLifitegrast | 90 | $134,077 |
| Cyclosporine | 130 | $58,823 |
| RocklatanNetarsudil Mesylat/Latanoprost | 101 | $49,442 |
| Prednisolone Acetate | 1,137 | $44,234 |
| CombiganBrimonidine Tartrate/Timolol | 83 | $40,428 |
| LumiganBimatoprost | 79 | $40,422 |
| RhopressaNetarsudil Mesylate | 68 | $29,015 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 89 | $24,574 |
| Alphagan PBrimonidine Tartrate | 50 | $20,315 |
| MieboPerfluorohexyloctane/Pf | 20 | $19,867 |
| MoxifloxacinMoxifloxacin Hcl | 544 | $14,968 |
| Brimonidine Tartrate | 215 | $14,453 |
| IyuzehLatanoprost/Pf | 24 | $13,049 |
| VyzultaLatanoprostene Bunod | 25 | $11,500 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan, Lumigan, Alphagan P | $2,336 | $272,654388 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo, Vyzulta | $288 | $165,444135 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $121 | $78,457169 claims |
| AlconSimbrinza | $1,037 | $24,57489 claims |
| Kala Pharmaceuticals, Inc.Eysuvis | $300 | $10,36019 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate, Lotemax | $200 | $8,38642 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 279 ophthalmology providers in Connecticut.
Other ophthalmology in Putnam
- John HuangHartford$267K
- Amir CohenNew Haven$266K
- James MurphyHamden$176K
- James TalbotNew Canaan$47K
- Paul KangNew Haven$40K
- Anish ShahNorwich$38K
- Michael KovalFarmington$35K
- Scott SpectorNorwalk$23K
- Madina FalconeFarmington$23K
- Flora LevinBridgeport$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.